These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33231360)

  • 1. White matter hyperintensities at critical crossroads for executive function and verbal abilities in small vessel disease.
    Camerino I; Sierpowska J; Reid A; Meyer NH; Tuladhar AM; Kessels RPC; de Leeuw FE; Piai V
    Hum Brain Mapp; 2021 Mar; 42(4):993-1002. PubMed ID: 33231360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Strategically Located White Matter Hyperintensities on Cognition in Memory Clinic Patients with Small Vessel Disease.
    Biesbroek JM; Weaver NA; Hilal S; Kuijf HJ; Ikram MK; Xu X; Tan BY; Venketasubramanian N; Postma A; Biessels GJ; Chen CP
    PLoS One; 2016; 11(11):e0166261. PubMed ID: 27824925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Painting by lesions: White matter hyperintensities disrupt functional networks and global cognition.
    Crockett RA; Hsu CL; Dao E; Tam R; Eng JJ; Handy TC; Liu-Ambrose T
    Neuroimage; 2021 Aug; 236():118089. PubMed ID: 33882347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterising the grey matter correlates of leukoaraiosis in cerebral small vessel disease.
    Lambert C; Sam Narean J; Benjamin P; Zeestraten E; Barrick TR; Markus HS
    Neuroimage Clin; 2015; 9():194-205. PubMed ID: 26448913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Microbleeds and White Matter Hyperintensities are Associated with Cognitive Decline in an Asian Memory Clinic Study.
    Gyanwali B; Lui B; Tan CS; Chong EJY; Vrooman H; Chen C; Hilal S
    Curr Alzheimer Res; 2021; 18(5):399-413. PubMed ID: 34420506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study.
    Xia Y; Shen Y; Wang Y; Yang L; Wang Y; Li Y; Liang X; Zhao Q; Wu J; Chu S; Liang Z; Wang X; Qiu B; Ding H; Ding D; Cheng X; Dong Q
    Aging (Albany NY); 2020 May; 12(9):8506-8522. PubMed ID: 32388497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractal dimension of cerebral white matter: A consistent feature for prediction of the cognitive performance in patients with small vessel disease and mild cognitive impairment.
    Pantoni L; Marzi C; Poggesi A; Giorgio A; De Stefano N; Mascalchi M; Inzitari D; Salvadori E; Diciotti S
    Neuroimage Clin; 2019; 24():101990. PubMed ID: 31491677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategic white matter hyperintensity locations for cognitive impairment: A multicenter lesion-symptom mapping study in 3525 memory clinic patients.
    Coenen M; Kuijf HJ; Huenges Wajer IMC; Duering M; Wolters FJ; Fletcher EF; Maillard PM; ; Barkhof F; Barnes J; Benke T; Boomsma JMF; Chen CPLH; Dal-Bianco P; Dewenter A; Enzinger C; Ewers M; Exalto LG; Franzmeier N; Groeneveld O; Hilal S; Hofer E; Koek DL; Maier AB; McCreary CR; Padilla CS; Papma JM; Paterson RW; Pijnenburg YAL; Rubinski A; Schmidt R; Schott JM; Slattery CF; Smith EE; Steketee RME; Sudre CH; van den Berg E; van der Flier WM; Venketasubramanian N; Vernooij MW; Xin X; DeCarli C; Biessels GJ; Biesbroek JM
    Alzheimers Dement; 2023 Jun; 19(6):2420-2432. PubMed ID: 36504357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesion location and cognitive impact of cerebral small vessel disease.
    Biesbroek JM; Weaver NA; Biessels GJ
    Clin Sci (Lond); 2017 Apr; 131(8):715-728. PubMed ID: 28385827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lesion location matters: The relationships between white matter hyperintensities on cognition in the healthy elderly.
    Lampe L; Kharabian-Masouleh S; Kynast J; Arelin K; Steele CJ; Löffler M; Witte AV; Schroeter ML; Villringer A; Bazin PL
    J Cereb Blood Flow Metab; 2019 Jan; 39(1):36-43. PubMed ID: 29106319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural network changes in cerebral small vessel disease.
    Tuladhar AM; Tay J; van Leijsen E; Lawrence AJ; van Uden IWM; Bergkamp M; van der Holst E; Kessels RPC; Norris D; Markus HS; De Leeuw FE
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):196-203. PubMed ID: 31744851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic white matter hyperintensity locations associated with post-stroke cognitive impairment: A multicenter study in 1568 stroke patients.
    Coenen M; de Kort FA; Weaver NA; Kuijf HJ; Aben HP; Bae HJ; Bordet R; Chen CP; Dewenter A; Doeven T; Dondaine T; Duering M; Fang R; van der Giessen RS; Kim J; Kim BJ; de Kort PL; Koudstaal PJ; Lee M; Lim JS; Lopes R; van Oostenbrugge RJ; Staals J; Yu KH; Biessels GJ; Biesbroek JM
    Int J Stroke; 2024 Oct; 19(8):916-924. PubMed ID: 38651756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical associations of T2-weighted lesion load and lesion location in small vessel disease: Insights from a large prospective cohort study.
    Altermatt A; Gaetano L; Magon S; Bauer L; Feurer R; Gnahn H; Hartmann J; Seifert CL; Poppert H; Wuerfel J; Radue EW; Kappos L; Sprenger T
    Neuroimage; 2019 Apr; 189():727-733. PubMed ID: 30685330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Atrophy of the Caudate Nuclei, Global Brain Atrophy, Cerebral Small Vessel Disease and Mild Parkinsonian Signs in Neurologically and Cognitively Healthy Subjects Aged 45-84 Years: A Crosssectional Study.
    Camarda C; Torelli P; Pipia C; Battaglini I; Azzarello D; Rosano R; Ventimiglia GD; Sottile G; Cilluffo G; Camarda R
    Curr Alzheimer Res; 2018; 15(11):1013-1026. PubMed ID: 29962342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural network efficiency predicts cognitive decline in cerebral small vessel disease.
    Boot EM; Mc van Leijsen E; Bergkamp MI; Kessels RPC; Norris DG; de Leeuw FE; Tuladhar AM
    Neuroimage Clin; 2020; 27():102325. PubMed ID: 32622317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.
    van Leijsen EMC; Tay J; van Uden IWM; Kooijmans ECM; Bergkamp MI; van der Holst HM; Ghafoorian M; Platel B; Norris DG; Kessels RPC; Markus HS; Tuladhar AM; de Leeuw FE
    Hippocampus; 2019 Jun; 29(6):500-510. PubMed ID: 30307080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter integrity in small vessel disease is related to cognition.
    Tuladhar AM; van Norden AG; de Laat KF; Zwiers MP; van Dijk EJ; Norris DG; de Leeuw FE
    Neuroimage Clin; 2015; 7():518-24. PubMed ID: 25737960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between White Matter Hyperintensities Related Gray Matter Volume and Cognition in Cerebral Small Vessel Disease.
    Wang Y; Yang Y; Wang T; Nie S; Yin H; Liu J
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105275. PubMed ID: 32992182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Covariance Networks and Their Association with Age, Features of Cerebral Small-Vessel Disease, and Cognitive Functioning in Older Persons.
    Foster-Dingley JC; Hafkemeijer A; van den Berg-Huysmans AA; Moonen JE; de Ruijter W; de Craen AJ; van der Mast RC; Rombouts SA; van der Grond J
    Brain Connect; 2016 Nov; 6(9):681-690. PubMed ID: 27506114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Tan L; Kandiah N
    Parkinsonism Relat Disord; 2016 Oct; 31():34-40. PubMed ID: 27397577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.